Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 27, 2018
Patent Application Number
15070839
Date Filed
March 15, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
